BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

News: BNO Bionomics Announces Results Of BNC210 Agitation Trial

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    26/06/19
    10:10
    Post #: 39241375

    June 26 (Reuters) - Bionomics Ltd (BNO) :

    • RESULTS OF AGITATION TRIAL INDICATED THAT BNC210 TREATMENT DID NOT DIFFERENTIATE FROM PLACEBO ON PRIMARY & SECONDARY EFFICACY END POINTS
    • TRIAL RESULTS DO NOT SUPPORT FURTHER DEVELOPMENT OF BNC210 FOR TREATMENT OF AGITATION, TO INVEST IN PURSUING DOSE STUDY FOR PTSD
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS New targets and high-grade intercepts drive Bullabulling drill expansion
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner
right-arrow Created with Sketch.
BML Boab Metals secures path to full ownership of Sorby Hills Project
right-arrow Created with Sketch.
NEWS Outstanding thick high-grade gold revealed in first Greenewood assays
right-arrow Created with Sketch.
NEWS How to handle a financial crisis and turn setbacks into setups
right-arrow Created with Sketch.
NEWS The 4 sectors poised to benefit from Australia's immigration wave
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.